Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.061 | 0.7 |